News Conference News ACC 2024 TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England Yael L. Maxwell April 05, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites Michael O'Riordan February 13, 2024
News Conference News STS 2024 Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3 Yael L. Maxwell February 09, 2024
News Conference News STS 2024 SAVR After Failed TAVI on the Rise, With High Mortality Yael L. Maxwell February 05, 2024
News Conference News STS 2024 TAVI, SAVR Almost Equally Performed in California Patients Under 60 Yael L. Maxwell February 01, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024
News Daily News Socioeconomics Mire Access to All AVR Options for Aortic Stenosis Yael L. Maxwell January 22, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Conference News PCR London Valves 2023 Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge Shelley Wood November 27, 2023
News Conference News TCT 2023 Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots Caitlin E. Cox November 03, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2023 Shelley Wood November 01, 2023
News Conference News TCT 2023 SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC Yael L. Maxwell October 30, 2023
News Conference News TCT 2023 ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation Todd Neale October 26, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
News Daily News SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry Yael L. Maxwell October 20, 2023